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Abstract: INTRODUCTION Circulating histones have been identified as mediators of damage in animal
models of sepsis and in patients with trauma-associated lung injury. Despite existing controversies on
actual histone concentrations, clinical implications and mechanism of action in various disease conditions,
histone levels in human sepsis, association with disease progression and mediated effects on endothelial
and immune cells remain unreported. This study aimed to determine histone levels and its clinical
implication in septic patients and to elucidate histone-mediated effects ex-vivo. METHODS Histone
levels, endogenous activated protein C (APC) levels and clinical data from two independent cohorts
of septic patients were obtained. Histone levels were compared with various control groups including
healthy individuals, intensive care unit (ICU) patients without sepsis, ICU patients with multiple organ
failure and patients with minor or multiple trauma, all without infection. Endothelial and monocytic cells
were stimulated with histones. Cellular integrity and sepsis prototypical cytokines were evaluated. The
mechanism of action of histones via Toll-like receptor 4 (TLR4) was evaluated using a function blocking
antibody. Histone degradation in plasma was studied by immunoblotting. RESULTS Histone H4 levels
were significantly elevated in patients with sepsis (cohort I; n = 15 and cohort II; n = 19) versus ICU
controls (n = 12), patients with multiple organ failure (n = 12) or minor trauma (n = 7), associated
with need for renal replacement therapy and decrease in platelet count during disease progression, and
remarkably were significantly associated with increased mortality rates in septic patients (ICU-, 28 day-
and 90 day mortality rates). There was an inverse correlation between plasma histones and endogenous
APC levels. Histone stimulation induced the release of sepsis prototypic cytokines and decreased cell
integrity indicated by a significant increase of lactate dehydrogenase (LDH) and propidium iodide (PI)
staining. Blocking of TLR4 decreased cellular cytotoxicity on endothelial cells. The calculated half-life
of histones in spiked plasma was 4.6 minutes. CONCLUSIONS Histone levels in septic patients are
significantly increased and might mediate disease aggravation by cellular injury and inflammation via
TLR4 signaling, which potentially results in multiple organ failure and fatal outcome.
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Abstract
Introduction: Circulating histones have been identified as mediators of damage in animal models of sepsis and in
patients with trauma-associated lung injury. Despite existing controversies on actual histone concentrations, clinical
implications and mechanism of action in various disease conditions, histone levels in human sepsis, association
with disease progression and mediated effects on endothelial and immune cells remain unreported. This study
aimed to determine histone levels and its clinical implication in septic patients and to elucidate histone-mediated
effects ex-vivo.
Methods: Histone levels, endogenous activated protein C (APC) levels and clinical data from two independent
cohorts of septic patients were obtained. Histone levels were compared with various control groups including
healthy individuals, intensive care unit (ICU) patients without sepsis, ICU patients with multiple organ failure and
patients with minor or multiple trauma, all without infection. Endothelial and monocytic cells were stimulated with
histones. Cellular integrity and sepsis prototypical cytokines were evaluated. The mechanism of action of histones
via Toll-like receptor 4 (TLR4) was evaluated using a function blocking antibody. Histone degradation in plasma was
studied by immunoblotting.
Results: Histone H4 levels were significantly elevated in patients with sepsis (cohort I; n = 15 and cohort II; n = 19)
versus ICU controls (n = 12), patients with multiple organ failure (n = 12) or minor trauma (n = 7), associated with
need for renal replacement therapy and decrease in platelet count during disease progression, and remarkably
were significantly associated with increased mortality rates in septic patients (ICU-, 28 day- and 90 day mortality
rates). There was an inverse correlation between plasma histones and endogenous APC levels. Histone stimulation
induced the release of sepsis prototypic cytokines and decreased cell integrity indicated by a significant increase of
lactate dehydrogenase (LDH) and propidium iodide (PI) staining. Blocking of TLR4 decreased cellular cytotoxicity on
endothelial cells. The calculated half-life of histones in spiked plasma was 4.6 minutes.
Conclusions: Histone levels in septic patients are significantly increased and might mediate disease aggravation by
cellular injury and inflammation via TLR4 signaling, which potentially results in multiple organ failure and fatal
outcome.
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Introduction
Sepsis is a multifactorial life-threatening syndrome aris-
ing from the immune response to invading microorgan-
isms, resulting in excessive cell activation and tissue
damage [1,2]. Based on current understanding of the
pathophysiology of the host response, endothelial activa-
tion and dysfunction [3], as well as culminating multiple
organ failure, are known hallmarks of the clinical course,
which determines the prognosis of patients [4-6]. Multiple
immune activators during systemic inflammation known
as pathogen-associated molecular pattern (PAMPs) [7]
and damage-associated molecular patterns (DAMPs) [8]
have been reported to be involved in the aggravation of
host response.
Recently reported is a concept implicating extracellular
histone isoforms, mainly histone H4 (H4), as a result of
host response, which aggravates maladaptive mecha-
nisms through a direct action on endothelial cells [9]
and platelets [10]. Furthermore, free histones in circula-
tion mediate extensive cellular damage, hemostatic im-
balance and amplification of the inflammatory response
by inducing cytokine production as reported in an ani-
mal model of sepsis. Intravenous injection of purified
histones in mice elicited thrombocytopenia, neutrophil
migration, and organ failure mimicking the pathophysio-
logical signature of sepsis [9]. Interestingly, co-infusion
of histones with APC [9] or intravenous injection of his-
tones in toll-like receptor (TLR)4-null mice abrogates
histone induced effects [11]. Additionally, histones have
been reported to mediate fatal liver injury in mice [11],
and have recently been identified as essential effectors of
C5aR- and C5L2-mediated tissue damage and inflamma-
tion in acute lung injury [12] and in trauma-associated
lung injury in humans, with concentrations ranging be-
tween 10 and 280 μg/ml as measured using immuno-
blotting [13].
In this study, we sought to investigate histone levels in
septic patients and associations with clinical data and ac-
tivated protein C (APC). In vitro, we investigated the
role of histones in cellular damage, inflammatory re-




Institutional ethical approval was given by the local eth-
ics committee of the medical faculty of Friedrich-Schiller
University Hospital in Jena (2160-11/07, 2712-12/09)
and the local ethics committee Zurich (kantonale Ethik-
kommission Zürich, KEK: StV26-2007), and written in-
formed consent of each patient was obtained.
ICU controls and patients with severe sepsis or septic
shock according to the American College of Chest Physi-
cians and the Society of Critical Care Medicine (ACCP/
SCCM) [14] were prospectively enrolled. Cohort I included
15 patients with sepsis from various origins during disease
progression. Cohort II included 19 patients suffering from
postoperative anastomosis insufficiency after major abdom-
inal surgery (Table 1). Blood samples were collected in
citrated anticoagulant tubes within 24 hours at onset of
sepsis (day 1) in cohort I and at onset of sepsis, and on day
3 and day 5 in cohort II. Plasma was separated by centrifu-
gation at 2000 × g for 10 minutes. Patient characteristics
from both cohorts were obtained (Table 1). Additionally,
various clinical scores and laboratory findings including
age, sex, International classification of Disease 10th revision
(ICD-10) diagnosis, length of stay (LOS), outcome, acute
physiology and chronic health evaluation II score (APA-
CHE II), simplified acute physiology score (SAPS), sequen-
tial organ failure assessment score (SOFA), ventilator
assistance, vasopressor treatment, creatinine levels and re-
quirement for renal replacement therapy (RRT), bilirubin,
C-reactive protein (CRP), partial thromboplastin time
(PTT), platelet count, leukocyte count and procalcitonin
levels were obtained from the patient data monitoring sys-
tem. Platelet increase was defined as an increase in platelet
count >30% on day 5 of sepsis progression as compared to
platelet count on day 1, while platelet decrease was de-
fined as a fall in platelet count > 30% on day 5 of sepsis as
compared to platelet count at onset of sepsis.
For comparison of histone concentrations, we in-
cluded various control groups, which included; 5 healthy
individuals, 12 ICU patients without sepsis, 12 ICU pa-
tients with multiple organ failure (MOF), 7 patients with
distal radius fracture (minor trauma), and 12 patients
with multiple trauma (nonconsecutive patients with
thoracic injury; age: median 73 years, range 42 to 92
years; injury severity score (ISS): median 34, range 17 to
66; with blunt chest trauma; male/female: 8/3; lethality
27.3% [3/11]). The control groups showed no signs of
Table 1 Clinical characteristics of patients at study
enrollment
Patient characteristics Cohort I Cohort II
Number of patients (n) 15 19
Age, years, median (IQR) 72 (48 to 77) 69 (45 to 73)
Gender male, n (%) 8 (53.3) 13 (68.4)
ICU survivor, n (%) 10 (66.7) 12 (63.2)
28-day survivors, n (%) n.d. 14 (73.7)
90-day survivors, n (%) n.d. 7 (36.8)
APACHE-II, median (IQR) 24 (18 to 30) 19 (15 to 26)
SAPS-II, median (IQR) 44 (33 to 73) 44 (34 to 52)
SOFA, median (IQR) 10 (6 to 13) 10 (6 to 11)
APACHE II, acute physiology and chronic health evaluation II; SAPS, simplified
acute physiology score; SOFA, sequential organ failure assessment score.
n.d. not determined.
Ekaney et al. Critical Care 2014, 18:543 Page 2 of 9
http://ccforum.com/content/18/5/543
acute infection. Collection of trauma samples was per-
formed following completion of other groups.
Enzyme-linked immunosorbent assay (ELISA)
Human histone H4 and APC ELISA kits were obtained
from USCN Life Science (Wuhan, China). Standards and
patient samples were run in duplicates according to
manufacturer’s instructions.
Stimulation assays
Commercially available calf thymus histones (Sigma,
Deisenhofen, Germany) were passed through a high affinity
endotoxin detoxi-gel (Thermo Fisher Scientific, Waltham,
Massachusetts, USA) before use in all stimulation assays to
remove potential endotoxin contamination. Purified calf
thymus histones were used for stimulatory experiments on
immortalized human microvascular endothelial cells
(HMEC) and human monocytic cells (MM6). For in vitro
assays, 500,000 cells per well seeded in six-well plates were
stimulated with 10 ng/ml and 50 μg/ml of histones in cell
culture media supplemented with 1% fecal calf serum. Un-
stimulated cells were used as negative control. Experiments
were performed at least in triplicates.
Human TLR4 neutralization
Functional antibody against human TLR4 (PAb hTLR4)
and control antibody (PAb Control) were obtained from
Invivogen (San Diego, CA, USA). A total of 25,000 cells
were seeded in 96-well plates. Antibodies were diluted
to a final concentration of 5 μg/ml and incubated at 37°C
for 10 minutes. A 50 μg/ml histone concentration was
used for stimulation and cells were incubated overnight
for 24 hours. Supernatant was collected for lactate de-
hydrogenase (LDH) measurements and cells were stained
with propidium iodide (PI).
Fluorescent staining (Propidium iodide staining)
Cells were detached with 1X trypsin and washed three
times with 1X sterile PBS. Cells were resuspended in
1 ml of 1X PBS and incubated with 10 μg/ml PI dye so-
lution (Sigma, St. Louis, USA) in the dark for 5 minutes
at room temperature. Fluorescent intensity was mea-
sured by flow cytometry.
Lactate dehydrogenase measurement
LDH levels in cell culture supernatant were measured at
0 hours and 24 hours after histone stimulation with a
commercially available kit (Roche, Germany) according
to manufacturer’s instructions. Absorbance was read at
490 nm using a spectrophotometer.
Cytokine measurements
For quantification of cytokines in cell culture super-
natant after histone stimulation, a cytometric bead assay
(CBA) was performed according to the manufacturer’s
instructions (human inflammation kit; BD Biosciences,
Germany) and measured by flow cytometry using a
FACS calibur.
Determination of histone stability
Blood from three healthy volunteers was drawn into
citrated anticoagulant tubes and plasma was separated
by centrifugation at 2000 × g for 10 minutes. Plasma
was spiked with calf thymus histones to a concentration
of 100 μg/ml and incubated at 37°C with mild shaking
for 5, 10, 15 and 30 minutes. Plasma was separated by
western blotting and detection of histones was per-
formed using anti-histone H3 antibodies (Cell signalling,
USA). Determination of half-life was performed by ap-
proximation of the degradation process reaching a plat-
eau phase.
Statistical analysis
Levels of histone measurements are given as median
including the 25th and 75th IQR. Analysis of variance
(ANOVA) on ranks was used to determine differences
between histone concentrations at onset of sepsis, day 3
and day 5. The Student t-test or Mann-Whitney test was
used to compare independent variables where applicable.
Multivariate linear regression analysis was used to predict
clinical characteristics that were independently associated
with histone levels. Spearman correlation coefficient (r)
was used to determine the correlations between independ-
ent parameters and histone levels. Statistical significance
was set at P <0.05. Densitometry analysis was performed
using AIDA software and a single-phase decay analysis for
calculation of half-life was performed using Graph Pad
Prism 5.0.
Results
Histone levels in septic patients correlate with disease
progression and mortality
In cohort I, histone H4 levels were significantly elevated
compared to ICU controls (sepsis cohort I: median 0.35,
IQR 0.2 to 0.46) versus ICU controls: median 0.06 (0.05
to 0.07) ng/ml, P <0.05; Figure 1A). In cohort II, histone
H4 levels were significantly elevated during the course
of sepsis on day 1, day 3 and day 5 as compared to the
ICU control group (sepsis cohort II, day 1: median 0.37
(0.16 to 0.61), day 3: median 0.28 (0.08 to 0.53), day 5:
median 0.41 (0.22 to 0.62) versus ICU controls: median
0.06 (0.05 to 0.07) ng/ml, P <0.05; Figure 1A). Histone
concentrations in both cohorts ranged from 0.01 to
1.08 ng/ml with an inter-assay coefficient of variation
(CV) <10%. However, detection of histones in plasma
of patients by immunoblotting was not possible be-
cause the observed concentrations were far below the
limit of detection by this method (approximately 500
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ng/ml). Histone levels on day 1 in both cohorts of sep-
tic patients were also significantly elevated compared
to patients with MOF (sepsis cohort I: median 0.35
(IQR 0.2 to 0.46), sepsis cohort II: median 0.37 (0.16 to
0.62) versus MOF: median 0.08 (IQR 0.05 to 0.11) ng/
ml, P <0.05) and minor trauma patients (sepsis cohort
I: median 0.35 (IQR 0.2 to 0.46), sepsis cohort II: me-
dian 0.37 (0.16 to 0.62) versus minor trauma: median
0.11 (IQR 0.07 to 0.13) ng/ml, P <0.05). However, his-
tone levels in multiple trauma patients were 3-fold
higher than levels measured in septic patients with
concentrations up to 3 ng/ml (multiple trauma: median
0.98 (IQR 0.46 to 1.46) versus sepsis cohort I: median
0.35 (IQR 0.2 to 0.46), sepsis cohort II: median 0.37
(0.16 to 0.62) ng/ml, P <0.05, Figure 1A).
Analyses of the clinical data from cohort II revealed that
patients with a decline in platelet count >30% on day 5 of
sepsis progression demonstrated significantly elevated his-
tone levels on day 1 compared to patients with an increase
in platelet count >30% (decreased platelets: median 0.23
(0.16 to 0.32) versus increased platelets: median 0.06 (0.02
to 0.12) ng/ml, P <0.05; Figure 1B). Due to unvaried platelet
count over time, two patients were not included in this sub-
group analysis. Furthermore, patients who required RRT
until day 5 presented significantly elevated histone levels on
day 1 as compared to patients without subsequent need for
RRT (need for RRT: median 0.23 (0.11 to 0.38) versus with-
out need for RRT: median 0.09 (0.02 to 0.19) ng/ml, P <0.05;
Figure 1B). With respect to ICU- and 28-day mortality, on
day 1 non-survivors presented with significantly elevated
concentrations compared to survivors (ICU mortality, non
survivors: median 0.54 (0.34 to 0.71) versus survivors:
median 0.21 (0.06 to 0.4) ng/ml, P <0.05; 28-day mortality,
non survivors: median 0.67 (0.25 to 0.75) versus survivors:
median 0.25 (0.07 to 0.45) ng/ml, P <0.05). Remarkably, this
was also evident for 90-day mortality (non-survivors: me-
dian 0.48 (0.36 to 0.68) versus survivors: median 0.19 (0.06
to 0.28) ng/ml, P <0.05; Figure 1B). Multivariate linear
regression analysis including APACHE-II score, SOFA score,
CRP, white blood cells (WBC), creatinine, and platelet count
as independent variables identified WBC (P <0.05, R2 =
0.64) and SOFA score (P <0.05, R2 = 0.64) as predictors for
histone levels at onset of sepsis (day 1).
Histone levels negatively correlate with endogenous APC
Endogenous APC levels in cohort II at day 1, day 3 and day
5 were analyzed. APC levels were significantly elevated as
compared to healthy controls (day 1: median 6.14 (IQR 5.8
to 6.9), day 3: median 6.49 (6.06 to 8.10), day 5: median
7.15 (5.21 to 7.68) ng/ml versus controls: median 4.69 (4.16
to 5.51) ng/ml; P <0.05; Figure 2A). APC levels were in-
versely correlated with histone levels (r = −0.584, P <0.05;
Figure 2B). Furthermore, elevated APC levels were identi-
fied as an independent predictor of decreased histone levels
when included in the multivariate linear regression model
(P <0.001, R2 = 0.723).
Histones mediate cellular damage and induced the
cytokines production
The cytotoxic effects of histones on endothelial cells and
monocytes using 10 ng/ml and 50 μg/ml histone concentra-
tion were evaluated. There was no change in LDH release
Figure 1 Plasma histone H4 concentration in two independent cohorts of septic patients (Cohorts I and II) and associations with
disease progression and mortality. (A) Plasma histone concentration in sepsis cohort I (n = 15) and sepsis cohort II (n = 19) on day 1, day 3, day 5,
ICU controls (n = 12), patients with multiple organ failure (MOF) (n = 12), minor trauma (n = 7) and multiple trauma (n = 12) patients. All controls were
without signs of infection. *Mann-Whitney test (P <0.05) to compare independent groups. (B) Plasma histone H4 at day 1 associated with platelet
count at day 5, requirement for renal replacement at day 5, and outcome at day 90. *Mann-Whitney test, P <0.05. RRT+ indicates the requirement of
renal replacement therapy; RRT− indicates no requirement for renal replacement therapy.
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or PI fluorescence of the nuclei after stimulation with 10 ng/
ml. Histone concentration of 50 μg/ml led to cell death indi-
cated by significant high levels of LDH and PI positive cells
(P <0.001) (Figure 3A-D). The stimulation of monocytes
with 10 ng/ml histone concentration led to a significant
increase in TNF-α at 6 hours and IL-8 (6 hours, 24 hours,
P <0.05) while 50 μg/ml histones led to a marked increase
in sepsis-associated cytokines such as TNF-α, IL-6, IL-8,
and IL-1ß at 6 hours and IL-6, IL-8, and IL-1ß at 24 hours
(Figure 4A-D).
Blocking anti-TLR4 antibodies inhibits histone-induced
cytotoxicity
To evaluate the mode of action of histones, TLR4 sig-
naling via receptor neutralization was targeted. Pre-
treatment of endothelial cells with a specific TLR4
blocking antibody abrogated histone-induced increase
of cellular cytotoxicity as shown by both PI staining and
measurement of LDH release (P <0.05) after stimulation
with 50 μg/ml histones (Figure 5A-B).
Figure 2 Endogenous APC levels in patients with sepsis and correlation with plasma histone levels. (A) Endogenous activated
protein C (APC) levels in patients at onset of sepsis (day 1), day 3 and day 5. *Analysis of variance on ranks test (P <0.05) to compare
difference between APC levels on day 1, day 3 and day 5. (B) Endogenous APC levels negatively correlated with plasma histone levels.
*Spearman correlation (P <0.05).
Figure 3 Evaluation of cellular integrity and viability after histone stimulation of endothelial and monocytic cells. (A) Lactate dehydrogenase
(LDH) levels significantly increased in supernatant of human microvascular endothelial cells (HMEC) after 50 μg/ml histones stimulation for 24 h.
***Student’s t-test, P <0.001. (B) LDH levels significantly increased in supernatant of mono mac 6 (MM6) cells after 50 μg/ml histones stimulation
for 24 h. ***Student’s t-test, P <0.001. (C) Percentage of propidium iodide (PI)-positive HMEC cells significantly increased after 24 hours stimulation
with 50 μg/ml histones. *Student’s t-test, P <0.05. (D) Percentage of PI-positive MM6 cells significantly increased after 24 hours stimulation with
50 μg/ml histones. ***Student’s t-test, P <0.001.
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Determination of histone stability
In histone-spiked plasma, histone degradation over time
was measured by western blotting. We found a single
nonlinear regression exponential decay of histones in
plasma between 0 to 30 minutes. The half-life of his-
tones in three independent plasma samples was 4.6 mi-
nutes with an R2 of 0.9159 (Figure 6A-B). Interestingly,
after 30 minutes, degradation reached a plateau and no
further decline was observed up to 6 hours (data not
shown).
Discussion
The study demonstrated for the first time and in two in-
dependent cohorts of septic patients that plasma con-
centrations of extracellular histones are elevated during
human sepsis as compared to ICU controls. Interest-
ingly, the observed concentrations are similar in both
cohorts with low inter-assay variation. Histones were
also significantly increased during the course of disease
progression until day 5 of sepsis. This is in line with pre-
vious reports of an increase in histone concentration in
Figure 4 Cytokine production after histone stimulation. (A) IL-8 levels in supernatant from mono mac 6 (MM6) significantly increased after
10 ng/ml (P < 0.05) and 50 μg/ml stimulation for 6 and 24 hours. ***Student’s t-test, P <0.001. (B) IL-1ß levels in supernatant from MM6 significantly
increased after 50 μg/ml stimulation for 24 hours. **Student’s t-test, P <0.05. (C) IL-6 levels in supernatant from MM6 significantly increased after 50
μg/ml stimulation for 6 and 24 hours. ***Student’s t-test, P <0.001. (D) TNF-α levels in supernatant from MM6 increased after 6 hours with 10 ng/ml
and 50 μg/ml histone stimulation and 50 μg/ml stimulation after 24 hours. *Student’s t-test, P <0.05.
Figure 5 Histone effects after toll-like receptor 4 (TLR4) blockade. Blocking antibody control was obtained from animals housed
under the same condition as immunized animals to produce TLR4 antibody. (A) Percentage of propidium iodide (PI)-positive human
microvascular endothelial cells (HMEC) after 24 hours stimulation with 50 μg/ml histones with and without blocking of TLR4. ***Student’s
t-test, P <0.001. (B) Lactate dehydrogenase (LDH) release significantly decreased after blocking with specific TLR4 antibody compared to
histone-stimulated cells. **Student’s t-test, P <0.001.
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baboons after endotoxin challenge [9]. Interestingly, his-
tone levels were higher in septic patients compared to
patients with multiple organ failure without infection,
potentially indicating that the source of histones in cir-
culation could be strongly associated with the underlying
infection and the release of neutrophil extracellular traps
by neutrophils as demonstrated by others [15,16]. In
addition, we found lower levels of histones in patients
with minor trauma. This might be related to the limited
tissue damage representing a lower release of histones
into circulation, possible clearance of small quantities of
histones in circulation by macrophages or complete
eradication through active cleavage by proteases in
plasma such as endogenous activated protein C. Most
interestingly, we observed that in our cohort of patients
with multiple trauma, histone concentrations were higher
than levels found in septic patients. This supports previous
reports of elevated levels of histones found in patients
with blunt traumatic lung injury. Nevertheless, there was a
clear disparity in the concentrations of histones measured
in our multiple trauma patient cohort in the nanogram
range compared to the levels reported in traumatic lung
injury in the microgram range [13]. However, we could
not confirm histone concentrations by mass spectrometry
due to high abundance plasma proteins, which interfere
with the detection of low abundance proteins despite the
existence of high abundance protein depletion protocols.
Our efforts to quantify histones by immunoblotting also
failed because levels of histones found in patients were far
below the lower limit of detection for immunoblotting
(>500 ng/ml). Nevertheless, our investigation using two
independent cohorts of sepsis patients demonstrates and
justifies consistency and reproducibility of plasma histone
measurements in septic patients. In addition, the inclusion
of a second cohort enabled us to determine plasma his-
tones not only at onset of sepsis but also during disease
progression.
A hallmark of sepsis is the occurrence of renal failure
requiring renal replacement therapy [17]. Consistently,
our data suggested that higher levels of histones corre-
lated with the need for RRT. In addition, histones have
been shown to bind to platelets recruiting plasma adhe-
sion molecules, thereby promoting platelet aggregation
[10]. In our study, increased histone levels were associ-
ated with a decrease in platelet count corroborating this
concept. Interestingly, the occurrence of renal failure in
sepsis and thrombocytopenia is often associated with
high mortality [18,19]. The observed increase of plasma
histone levels in patients undergoing RRT also implies
that this increase might be a consequence of impaired
renal excretion of the protein. However, to the best of
our knowledge, there is no evidence that histones are ex-
creted and become present in urine, either in healthy or
pathophysiological conditions. On the other hand, micro-
vascular permeability is increased when renal microvascu-
lature is exposed to extracellular histones, released from
dying tubular epithelial cells [20]. In lipopolysaccharide
(LPS)-induced endotoxemia, neutralization of released his-
tones reduced tubular injury and an improved renal func-
tion as measured by creatinine levels was obvious [20],
identifying histones as mediators of acute kidney injury.
Strikingly, higher histone levels correlated with ICU-,
28- and 90-day mortality. Interestingly, thrombocytopenia
and organ dysfunction following histone administration
have also been demonstrated in mice [8,10]. Based on this
concept, it could be hypothesized that the interaction of
histones with the endothelium will result in endothelial
impairment. This damage leads to endothelial dysfunction
promoting platelet activation and aggregation, which im-
pairs microcirculation and results in organ dysfunction,
which is associated with an increased risk of death [21]. In
line with this, our ex-vivo findings further demonstrate
that histone mediated cytotoxicity on endothelium cells
and underline the results of Fuchs et al. demonstrating
Figure 6 Estimated degradation kinetics of histones in plasma. (A) Single-phase exponential decay fit of three healthy individuals and the
margin of error between samples. The half-life of histones (k) was 4.6 minutes with an R2 = 0.9159. (B) Western blotting showed decrease in
histone protein in plasma over time.
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direct platelet activation and aggregation [10]. Besides the
direct effects on platelets and cytotoxicity, we were able to
show an activation of immune cells which led to an in-
crease in sepsis prototypic cytokines in both low and high
concentrations of histone stimulation. From a pathome-
chanistic perspective, histone mediated effects might be ini-
tiated by TLR4 signaling as neutralization or blocking of the
TLR4 receptor in our study completely abrogated histone-
mediated cytotoxicity in our in vitro model. This underlines
a report by Xu et al. who showed that TLR4 knock-out mice
are protected from the fatal effects of histone infusion [11]
and also, at least in part, is in line with results from Abrams
et al. showing that TLR4 blocking results in a decrease in
cytokine production but not cytotoxicity.
We report lower concentrations of histones in the nano-
gram range during sepsis which contradicts reports on the
levels of histones measured in various species and diseases
(baboons after gram-negative challenge, approximately 15
μg/ml [9], in patients with blunt traumatic lung injury, ap-
proximately 10 to 280 μg/ml [13], 200 μg/ml in mice models
of acute lung injury [12]) and reported concentration used
in all histone stimulation studies so far (approximately 10 to
1000 μg/ml) [9,11-13,22]. It could also be speculated that
the discrepancy in histone levels released in animal (mice
and baboons) sepsis and the actual concentration measured
in plasma of our septic patients might be due to the treat-
ment with heparin in our septic ICU patients. Heparin is
highly negatively charged and was recently shown to bind to
positively charged histones reducing their cytotoxic effect
[22]. In line with other reports, the observed histone levels
in multiple trauma patients might be related to a higher de-
gree of tissue damage as represented by the injury severity
score [13]. In our cohort stratified according to need for
RRT on day 5 (cohort II), all of the patients underwent
anticoagulation either with heparin (2/3 of all our ICU pa-
tients) or citrate (1/3 of all our ICU patients). However,
measurements of histones to associate the level with the
clinical endpoint of need for RRT were performed prior to
initiation of anticoagulation for supportive treatment. From
the low number of samples with different anticoagulants,
from which one might interact with the readout, no com-
parison between these was performed.
We demonstrate also for the first time the ability of
plasma to degrade histones. As plasma was used for these
experiments, a potential binding of positively charged his-
tones to negatively charged membranes of erythrocytes
could be excluded. The observed fast initial degradation of
histones might be related to free proteases within the
plasma such as endogenous APC and might explain why
co-injection of histones with APC abrogated the lethal ef-
fects of histone injection in mice [9]. This might also sup-
port our finding of a negative correlation between histone
levels and APC in our septic patients. Unclear, however, is
the decline to a steady state of histones in plasma after 30
minutes. However, we speculate that the biological half-life
of histones in plasma could be affected by active metabo-
lites, binding of fragments to other proteins as well as re-
ceptor interactions and therefore will not follow the first
order kinetics with a fixed rate constant, because the gener-
ated fragments were also detected by the cited polyclonal
antibodies. Nevertheless, this finding indicates the need for
early centrifugation and measuring or freezing of the sam-
ples. Finally, further studies should elucidate the origin and
sources of circulating histones in plasma during sepsis.
Conclusions
In conclusion, our data provides evidence that plasma his-
tones are not only elevated in human sepsis but are associ-
ated with sepsis-related organ dysfunction, mediating
cellular damage and severe inflammation responses. The
observed effects might be mediated via the TLR4 receptor.
Key messages
 We analyzed histone concentrations in two
independent cohorts of septic patients. Histone
levels were significantly elevated in septic patients as
compared to ICU controls but lower in patients
with multiple trauma.
 Higher concentrations of histones associated
significantly with lower endogenous APC levels,
with the requirement for RRT, a decrease in platelet
count and were found to be higher in 28- and
90-day non-survivors.
 In vitro, histone stimulation of cultured endothelial
and monocytic cells decreased cellular integrity and
resulted in an increase in septic prototypic
cytokines.
 Histone-mediated action might be through TLR4.
The half-life of histone degradation in plasma was
4.6 minutes.
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